Literature DB >> 26296628

Mouse Models of Acute Respiratory Distress Syndrome: A Review of Analytical Approaches, Pathologic Features, and Common Measurements.

Famke Aeffner1, Brad Bolon2, Ian C Davis3.   

Abstract

Acute respiratory distress syndrome (ARDS) is a severe pulmonary reaction requiring hospitalization, which is incited by many causes, including bacterial and viral pneumonia as well as near drowning, aspiration of gastric contents, pancreatitis, intravenous drug use, and abdominal trauma. In humans, ARDS is very well defined by a list of clinical parameters. However, until recently no consensus was available regarding the criteria of ARDS that should be evident in an experimental animal model. This lack was rectified by a 2011 workshop report by the American Thoracic Society, which defined the main features proposed to delineate the presence of ARDS in laboratory animals. These should include histological changes in parenchymal tissue, altered integrity of the alveolar capillary barrier, inflammation, and abnormal pulmonary function. Murine ARDS models typically are defined by such features as pulmonary edema and leukocyte infiltration in cytological preparations of bronchoalveolar lavage fluid and/or lung sections. Common pathophysiological indicators of ARDS in mice include impaired pulmonary gas exchange and histological evidence of inflammatory infiltrates into the lung. Thus, morphological endpoints remain a vital component of data sets assembled from animal ARDS models.
© 2015 by The Author(s).

Entities:  

Keywords:  acute lung injury; acute respiratory distress syndrome; animal model; mouse; pneumonitis; pulmonary edema; respiratory

Mesh:

Year:  2015        PMID: 26296628     DOI: 10.1177/0192623315598399

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  45 in total

Review 1.  Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis.

Authors:  Xianbao Zhan; Fan Wang; Yan Bi; Baoan Ji
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-14       Impact factor: 4.052

2.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

Review 3.  Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.

Authors:  Colin E Evans; You-Yang Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

4.  Therapeutic blockade of CD54 attenuates pulmonary barrier damage in T cell-induced acute lung injury.

Authors:  Julia Svedova; Antoine Ménoret; Payal Mittal; Joseph M Ryan; James A Buturla; Anthony T Vella
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-04       Impact factor: 5.464

Review 5.  PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury.

Authors:  Jean Piero Margaria; Lucia Moretta; Jose Carlos Alves-Filho; Emilio Hirsch
Journal:  Biomedicines       Date:  2022-03-23

6.  Protective Effects of N-Acetylcysteine on Lipopolysaccharide-Induced Respiratory Inflammation and Oxidative Stress.

Authors:  Hongbai Chen; Nana Ma; Xiaokun Song; Guozhen Wei; Hongzhu Zhang; Jing Liu; Xiangzhen Shen; Xiangkai Zhuge; Guangjun Chang
Journal:  Antioxidants (Basel)       Date:  2022-04-29

7.  Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury.

Authors:  Zhihong Yuan; Brahmchetna Bedi; Ruxana T Sadikot
Journal:  J Vis Exp       Date:  2018-05-21       Impact factor: 1.355

8.  Role of Dual Oxidases in Ventilator-induced Lung Injury.

Authors:  Laura Cagle; Angela Linderholm; Lisa Franzi; Sabrina Hoehne; Jerold Last; Nicholas Kenyon; Beate Illek; Richart Harper
Journal:  Am J Respir Cell Mol Biol       Date:  2021-02       Impact factor: 6.914

9.  ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.

Authors:  C L Hrusch; S T Manns; D Bryazka; J Casaos; C A Bonham; M R Jaffery; K M Blaine; K A M Mills; P A Verhoef; A O Adegunsoye; J W Williams; M Y Tjota; T V Moore; M E Strek; I Noth; A I Sperling
Journal:  Mucosal Immunol       Date:  2017-05-10       Impact factor: 7.313

10.  Candidate genes and pathogenesis investigation for sepsis-related acute respiratory distress syndrome based on gene expression profile.

Authors:  Min Wang; Jingjun Yan; Xingxing He; Qiang Zhong; Chengye Zhan; Shusheng Li
Journal:  Biol Res       Date:  2016-04-18       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.